# Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease

> **NCT04003844** · PHASE4 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 45 (actual)

## Conditions studied

- Kawasaki Disease

## Interventions

- **DRUG:** Immunoglobulin G
- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT04003844
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2019-11-22
- **Final completion:** 2019-11-22
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04003844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04003844, "Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04003844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*